Dr. Kenneth I. Ataga, MD

  • Memphis, TN
  • Hematologist and oncologist
NPI1306886825PAC ID3375679145
Medicare services, 2023
19
Medicare patients, 2024
15
Part D claims, 2024
133
Publications
110
Clinical trials
6
Practice address
877 Jefferson Avenue, Memphis, TN 38103
Practice phone
Call (901) 545-7928
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Regional Medical Center

Hospital · Memphis, Tennessee

See all 6 affiliations

Find Dr. Ataga's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Kenneth I. Ataga is a hematologist and oncologist in Memphis, Tennessee

Dr. Ataga practices at Regional Medical Center in Memphis, Tennessee, part of Shelby County Government.

Dr. Ataga's NPI, 1306886825, was assigned on June 7, 2006. Dr. Ataga holds Tennessee license 57803.

NPI and contact details
Medicare PAC ID
3375679145
NPI enumeration date
June 7, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(901) 545-7928
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
62
Medical school graduation
1990

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Kenneth I. Ataga practices at Regional Medical Center in Memphis, Tennessee

Dr. Ataga's primary practice is Regional Medical Center, at 877 Jefferson Avenue, Memphis, TN 38103 in Shelby County. The practice phone is (901) 545-7928.

Source: Dmand AI Affiliation Data

Dr. Kenneth I. Ataga is affiliated with 3 sites of care and 3 medical groups

Dr. Ataga's primary practice is Regional Medical Center in Memphis, Tennessee, part of Shelby County Government. Dr. Ataga is also affiliated with Select Specialty Hospital - Memphis. The medical group on file is UT Regional One Physicians. Dmand AI also links Dr. Ataga to 2 more medical groups and 1 group practice or clinic, each named with a free account.

See all 6 affiliations for Dr. Ataga

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Kenneth I. Ataga's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ataga practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Regional Medical CenterAvailable with a free account
+2 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Ataga practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Shelby County Government and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Kenneth I. Ataga is one of 271 hematologists and oncologists in Tennessee

Hematology and oncology is Dr. Ataga's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Ataga's licenses on file in 2 states: Tennessee and North Carolina.

Specialties and state licenses

  • Hematology and oncology, TennesseePrimaryLicense 57803 · taxonomy 207RH0003X
  • North Carolina licenseLicense 9700849

Hematologists and oncologists near Dr. Ataga

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Kenneth I. Ataga billed Medicare for 19 services in 2023

CMS data shows 19 Medicare services from Dr. Ataga across 1 procedure code in 2023, all of them office visits, for 15 Medicare patients. Medicare paid $1,210 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 202319
Medicare patients15
Paid by Medicare$1,210
Procedure codes1

Dr. Ataga's Medicare services by type, 2022 to 2023

  • 2022
  • 2023
Office and hospital visits
2022: 332023: 1942%

Dr. Ataga compared with the Tennessee median for hematologists and oncologists, 2023

  • Dr. Ataga
  • Tennessee median
Medicare services
19vs 81898% below
Medicare patients
15vs 28795% below
Part D claims
77vs 50885% below

Medians across 259 hematologists and oncologists in Tennessee with Dmand AI profiles that report each measure.

Dr. Ataga's most billed Medicare procedure codes, 2023

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Ataga

Need commercial claims for Dr. Ataga?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ataga and other hematologists and oncologists in Tennessee.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Kenneth I. Ataga treated 15 Medicare patients in 2024, average age 49

CMS counts 15 Medicare patients who saw Dr. Ataga in 2024. 73% of them have high blood pressure. Their average risk score is 5.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ataga's median patient age at 41, with 45% women.

Medicare patients, 202415
Average age49
Average risk score5.30

Chronic conditions among Dr. Ataga's Medicare patients, 2024

  1. High blood pressure73%

Share of Medicare patients with each condition. A patient can have several.

Dr. Ataga's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 41

Patient panel by sex, all payers

  • Women45%
  • Men55%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Kenneth I. Ataga wrote 133 Medicare Part D claims in 2024

In 2024, Dr. Ataga wrote 133 Medicare Part D claims for 18 patients. 70% of them were for generic drugs. CMS names the drug for 77 of them, across 5 drugs with 11 or more claims each, at $320,430 in total drug cost. In 2023, CMS named 103 claims across 5 drugs.

Part D claims, 2024133
Drugs named by CMS5
Total drug cost$320,430
Part D patients18

Dr. Ataga's Part D claims by kind of drug, 2024

  • Generic93 claims70%
  • Brand-name40 claims30%

Dr. Ataga's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Ataga's Part D claims, 2024

  • Opioids16%21 of 133 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1032024: 7725%

Drugs named by CMS: 5 in 2024, 5 in 2023.

See all prescribing by Dr. Ataga

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Kenneth I. Ataga scored 81 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Ataga for performance year 2024, reported as part of a group. Dr. Ataga accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Ataga's MIPS scores, performance year 2024

  • 81of 100Final score
  • 64.6of 100Quality
  • 40of 100Improvement Activities
  • 77of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Ataga by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Kenneth I. Ataga has 110 publications on record

Dmand AI links 110 papers to Dr. Ataga, published from 2008 to 2025. 2021 was the busiest year, with 11. The most frequent topics are Anemia, Sickle Cell, Hydroxyurea and Hypertension, Pulmonary. Dr. Ataga has published most often in Br J Haematol. Dr. Ataga's most frequent co-authors are Payal Chandarana Desai, MD, Nigel S. Key, MD and Santosh Lumdas Saraf, MD.

Papers110
Years published2008 to 2025

Dr. Ataga's papers by year, 2016 to 2025

Topics Dr. Ataga writes about most

  • Anemia, Sickle Cell
  • Hydroxyurea
  • Hypertension, Pulmonary
  • Albuminuria
  • Double-Blind Method
  • Glomerular Filtration Rate
  • Kidney Diseases
  • Antisickling Agents

Dr. Ataga's most frequent co-authors

Recent publications by Dr. Ataga

See all 110 publications and co-authors

See who Dr. Ataga researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ataga works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Kenneth I. Ataga has worked on 6 clinical trials

Dmand AI links Dr. Ataga to 6 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Anemia, Sickle Cell, Anemia, Hemolytic, Congenital and Albuminuria. Novartis Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Ataga that name 2 trials.

Clinical trials with Dr. Ataga by phase

  1. NonePhase 1: no trials
  2. 2Phase 2: 2 trials
  3. 1Phase 3: 1 trial
  4. NonePhase 4: no trials

Conditions in Dr. Ataga's trials

  • Anemia, Sickle Cell
  • Anemia, Hemolytic, Congenital
  • Albuminuria
  • Kidney Failure, Chronic
  • Sickle Cell Trait

Investigators on the most trials with Dr. Ataga

Recent clinical trials with Dr. Ataga

See all 6 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Kenneth I. Ataga received $182,186 in industry payments from 2017 to 2025

CMS Open Payments shows 130 general payments to Dr. Ataga from 17 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 69% of the total. Novartis Pharmaceuticals Corporation paid the most, $47,437. It also lists 29 research payments totaling $10,971 from 2017 to 2025, naming 2 clinical trials.

General payments to Dr. Ataga by program year, 2017 to 2025

General payments to Dr. Ataga by kind, 2017 to 2025

$182.2Kin total
  • Consulting fees$126,28469%
  • Travel and lodging$34,28919%
  • Speaker and faculty fees$11,2836%
  • Honoraria$7,7504%
  • Food and beverage$2,5811%

Companies that paid Dr. Ataga the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Ataga

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Kenneth I. Ataga's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Kenneth I. Ataga

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Kenneth I. Ataga's NPI number?

Dr. Kenneth I. Ataga's NPI number is 1306886825. It was assigned on June 7, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Kenneth I. Ataga?

Dr. Kenneth I. Ataga is a hematologist and oncologist in Memphis, Tennessee. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Kenneth I. Ataga practice?

Dr. Ataga practices at 877 Jefferson Avenue, Memphis, TN 38103. Dr. Ataga's primary practice is Regional Medical Center in Memphis, Tennessee, part of Shelby County Government. Dmand AI also links Dr. Ataga to 2 medical groups and 1 group practice or clinic.

What is Dr. Kenneth I. Ataga's office phone number?

The practice phone on file for Dr. Ataga is (901) 545-7928.

What is Dr. Kenneth I. Ataga's medical license number?

Dr. Ataga holds Tennessee license 57803, one of the licenses on file in 2 states.

Which states has Dr. Kenneth I. Ataga been licensed in?

Dmand AI has state licenses on file for Dr. Ataga in Tennessee and North Carolina.

Which hospitals is Dr. Kenneth I. Ataga affiliated with?

Dr. Ataga practices at Regional Medical Center in Memphis, Tennessee. Dr. Ataga is also affiliated with Select Specialty Hospital - Memphis.

What medical group is Dr. Kenneth I. Ataga part of?

Dr. Ataga is linked to UT Regional One Physicians. Dmand AI links Dr. Ataga to 2 more medical groups.

Does Dr. Kenneth I. Ataga accept Medicare?

Yes. CMS data shows Dr. Ataga billed Medicare for 19 services in 2023, and Dr. Ataga accepts Medicare assignment.

What is Dr. Kenneth I. Ataga's MIPS score?

Dr. Ataga's MIPS final score for performance year 2024 is 81 out of 100, reported as part of a group.

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Kenneth I. Ataga see?

CMS counts 15 Medicare patients who saw Dr. Ataga in 2024, with an average age of 49.

What services does Dr. Kenneth I. Ataga bill to Medicare?

In 2023, Dr. Ataga's most billed Medicare services were office visit, established patient (99214).

What drugs does Dr. Kenneth I. Ataga prescribe most?

In 2024 Medicare Part D data, Dr. Ataga's most prescribed drugs by claims were Hydroxyurea, Endari and Adakveo.

Has Dr. Kenneth I. Ataga received payments from drug or device companies?

CMS Open Payments shows $182,186 in general payments to Dr. Ataga from 17 companies from 2017 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Kenneth I. Ataga been practicing?

Dr. Ataga graduated from medical school in 1990, 36 years ago.

Does Dr. Kenneth I. Ataga do research?

Dmand AI links 110 publications to Dr. Ataga, published from 2008 to 2025. Dr. Ataga has worked on 6 clinical trials.

Who does Dr. Kenneth I. Ataga publish with?

Dr. Ataga's most frequent co-authors are Payal Chandarana Desai, MD (15 shared papers), Nigel S. Key, MD (15 shared papers) and Santosh Lumdas Saraf, MD (7 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Tennessee by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)